AHRQ Delists Hospital Rep Safety Solutions Corp. as Patient Safety Organization for Non-Compliance

On September 9, 2026, the Agency for Healthcare Research and Quality (AHRQ), acting on behalf of the Department of Health and Human Services (HHS), officially delisted Hospital Rep Safety Solutions Corp. (PSO number P0264) from its roster of Patient Safety Organizations (PSOs). This decisive action, effective at 12:00 Midnight ET, stems from the organization's inability to rectify identified deficiencies, highlighting a crucial aspect of federal oversight in patient safety initiatives. The notice was formally published in the Federal Register on October 2, 2026.

The Patient Safety Act and PSOs

The delisting of Hospital Rep Safety Solutions Corp. is rooted in the framework established by the Patient Safety and Quality Improvement Act of 2005 (the Patient Safety Act) and its implementing regulation, the Patient Safety and Quality Improvement Final Rule (Patient Safety Rule). Enacted to encourage the voluntary reporting and analysis of medical errors and patient safety events, the Patient Safety Act provides a mechanism for healthcare providers to share information with designated PSOs on a privileged and confidential basis. This protection is designed to foster a culture of safety by allowing open discussion of errors without fear of legal discovery or punitive action, thereby facilitating systemic improvements in healthcare quality.

PSOs are entities or component organizations whose primary mission is to conduct activities aimed at improving patient safety and the quality of healthcare delivery. To be listed as a PSO, an entity must attest that it meets specific statutory and regulatory requirements. AHRQ administers these provisions, maintaining a public directory of both listed and delisted PSOs.

Grounds for Delisting

Under the Patient Safety Rule, a PSO can be delisted for several reasons. These include a voluntary relinquishment of status by the PSO, the expiration of its listing, or, as in this case, for cause. Delisting for cause occurs when a PSO is found to no longer meet the requirements set forth in the Patient Safety Act and Patient Safety Rule. AHRQ's notice explicitly states that Hospital Rep Safety Solutions Corp. was delisted for cause due to its failure to correct a finding of deficiency.

This action underscores AHRQ's role as a guardian of the PSO program's integrity. When an organization fails to maintain the standards necessary to operate as a PSO, the privilege and confidentiality protections it offers to reporting providers are jeopardized. Therefore, AHRQ's enforcement action serves to uphold the reliability and trustworthiness of the overall patient safety reporting system.

Implications of Delisting

For Hospital Rep Safety Solutions Corp., the delisting means it can no longer function as a federally recognized PSO. Any patient safety work product reported to or developed by the organization after the effective date of delisting will lose the federal privilege and confidentiality protections previously afforded under the Patient Safety Act. This loss of protection could have significant implications for providers who had been relying on Hospital Rep Safety Solutions Corp. for patient safety reporting.

From a broader perspective, this delisting reinforces the federal government's commitment to rigorous oversight of patient safety initiatives. It sends a clear message to all currently listed PSOs that continuous adherence to statutory and regulatory requirements is not merely a formality but a mandatory condition for participation in the program. The process involves identifying deficiencies and providing opportunities for correction, but ultimately, failure to remedy these issues results in removal from the program. Section 3.108(d) of the Patient Safety Rule mandates public notification of such removals, ensuring transparency in the regulatory process.

Future Landscape of Patient Safety

This incident highlights the dynamic nature of federal oversight in healthcare. While the PSO program aims to be collaborative and supportive of patient safety efforts, it also necessitates accountability. The delisting of Hospital Rep Safety Solutions Corp. by AHRQ, under the direction of Roger D. Klein, Director, serves as a reminder that the privilege and confidentiality protections are contingent upon ongoing compliance. It emphasizes the importance for healthcare entities to carefully vet their chosen PSOs and for PSOs themselves to maintain strict adherence to all governing regulations. The ongoing review and potential actions by AHRQ are vital for preserving the efficacy and credibility of the national patient safety framework.